GET READY MONKEY VIRUS IS BEING PROPAGANDISED BY THE LIBERAL MEDIA WHORES.

 

JEWISH KING JESUS IS COMING AT THE RAPTURE FOR US IN THE CLOUDS-DON'T MISS IT FOR THE WORLD.THE BIBLE TAKEN LITERALLY- WHEN THE PLAIN SENSE MAKES GOOD SENSE-SEEK NO OTHER SENSE-LEST YOU END UP IN NONSENSE.GET SAVED NOW- CALL ON JESUS TODAY.THE ONLY SAVIOR OF THE WHOLE EARTH - NO OTHER. 1 COR 15:23-JESUS THE FIRST FRUITS-CHRISTIANS RAPTURED TO JESUS-FIRST FRUITS OF THE SPIRIT-23 But every man in his own order: Christ the firstfruits; afterward they that are Christ’s at his coming.ROMANS 8:23 And not only they, but ourselves also, which have the firstfruits of the Spirit, even we ourselves groan within ourselves, waiting for the adoption, to wit, the redemption of our body.(THE PRE-TRIB RAPTURE)

 GET READY MONKEY VIRUS IS BEING PROPAGANDISED BY THE LIBERAL MEDIA WHORES.

JAGMEET SINGH NDP LEADER BETTER TAKE THAT TOWEL FROM HIS HEAD AND GET BACK TO INDIA. WERE HE CAN TELL INDIANS THAT THEY WANT MANDATORY PASSPORTS AND MANDATORY VACCINES. NOT CANADIANS. ALL THE LIBERALS AND THE FAKE NEWS BULLCRAP LIBERAL MEDIA ARE SETTING US UP FOR THE 1ST 2 VACCINE SHOTS OF THIS 2ND COVID OR MONKEY POX. I PREDICT THE FIRST 2 VACCINE SHOTS FOR MONKEY POX WILL BE JULY 1 AND AUG 1,2022. AS BILL GATES, TONY FAUCI, DADDYS LITTLE PRETTY BOY JUSTIN JUDAS TRUDEAU, BIDEN, AND ALL THE WORLD LEADERS. THEIR FOLLOWING THE SAME SCAM AS COVID-EXCEPT THEIR DOUBLEING THE LOCK DOWN TIME.

Wittgenstein @backtolife_2022-May 19
Jagmeet Singh says that Canadians want vaccine passports and mandatory vaccines.
Mrs. gc @ArtonFurniture-May 20
#jagmeetsingh the vast majority of #Canadians have been forced or face the consequences. Who are you kidding? @theJagmeetSingh
 What is the punishment?  OMG! being punishment for not get #vaccinated and what furture drugs will we ALL be forced to take.
#EndTheMandates-Quote Tweet-Ryan Gerritsen🇨🇦-@ryangerritsen- May 19
Jagmeet says there will be consequences for people not willing to get vaccinated. Oh really @theJagmeetSingh ? And what majority want to make their medical status public information? And for a failed product. We need to tell Trudeau’s puppet where to go.

Bill Gates Warns Of Epidemic That Could Kill Over 30 Million People-Bruce Y. LeeSenior Contributor-Feb 19, 2017,12:40am EST-This article is more than 5 years old.

Bill Gates, who last year was awarded the Presidential Medal of Freedom in part for his extensive... [+] global health work, now has a warning that you should not ignore.Bill Gates is a smart guy who knows something about global health. So when he gives a grave warning about a potential catastrophe, it's a good idea to listen. Yesterday, at the Munich Security Conference in Germany, the man who tops the Forbes richest person in the world list and is co-chair of the Bill and Melinda Gates Foundation said:Whether it occurs by a quirk of nature or at the hand of a terrorist, epidemiologists say a fast-moving airborne pathogen could kill more than 30 million people in less than a year. And they say there is a reasonable probability the world will experience such an outbreak in the next 10 to 15 years.

Gates Germ-Game Warning Motivates Smallpox Vaccine Discussions-Fact checked by Robert Carlson, MD-November 8, 2021

Policy Exchange recently hosted Mr. Bill Gates, Co-Chair of the Bill and Melinda Gates Foundation, and Rt Hon Jeremy Hunt MP, Chair of the Health Select Committee, who discussed the potential of future pandemics.  In a wide-ranging discussion on November 4, 2021, Gates called for a new international Pandemic Task Force, with a budget of about $1 billion per year. According to Microsoft's founder, governments must invest billions in research and development to prepare for future pandemics and smallpox terror strikes.This new effort would "germ game" potential pandemics and bioterrorist attacks such as smallpox attacks on airports. The Science Times reported germ games are ‘when government agencies practice scenarios of another pandemic catastrophe.’“You say, OK, what if a bioterrorist brought smallpox to 10 airports? You know, how would the world respond to that? “There are naturally-caused epidemics and bioterrorism-caused epidemics that could even be way worse than what we experienced today.”“And citizens expect their governments not to let that happen again,” Gates commented.Gates has previously issued similar warnings.In an April 2015 TED presentation, "The next outbreak? We're not ready," Gates warned of the hazards of a highly contagious virus and a major pandemic, stressing the importance of being prepared.Based on recent Centers for Disease Control and Prevention (CDC) vaccine advisory committee meetings, the U.S. is focused on the threat of smallpox.On November 3, 2021, following an introduction by Pablo Sanchez, M.D. Chair of the Orthopoxvirus workgroup, the CDC’s Advisory Committee on Immunization Practices reviewed the two presentations focused on the smallpox vaccine JYNNEOS. Produced by Bavarian Nordic, JYNNEOS was initially approved in 2019 by the U.S. Food and Drug Administration (FDA) and is indicated for preventing smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection.

ACAM2000 Smallpox Vaccine Ingredients -ACAM2000, developed by Acambis, is a second-generation lyophilized preparation of purified virus (grown in Vero cell line) in HEPES (hydroxyethyl piperazine ethanesulfonic acid)-buffered saline, pH 7.4, containing 1% to 4% human serum albumin USP, 5% mannitol, and trace amounts of antibiotics (100 U/mL polymyxin B and 100 µg/mL neomycin) (John Becher, RPh, CDC, personal communication, 2006). It must be reconstituted before use by the addition of a diluent.

ACAM2000 Smallpox Vaccine-Authored by-Staff-Updated May 18, 2022

Emergent BioSolutions ACAM2000 is a live vaccinia virus, a replication-competent vaccine, to protect against smallpox disease. The ACAM2000® vaccine does not contain variola and cannot cause smallpox. However, It includes the vaccinia virus, which belongs to the poxvirus family, genus Orthopoxvirus.The Emergent BioSolutions Inc. replication-competent smallpox vaccine consists of a live, infectious vaccinia virus that can be transmitted from the vaccine recipient to unvaccinated persons who have close contact with the inoculation site or with exudate from the site. The vaccinia virus may cause rash, fever, and head and body aches. ACAM2000 is approved for active immunization against smallpox disease for persons at high risk for smallpox infection. ACAM2000 is licensed in the U.S. by the Food and Drug Administration (FDA) (STN: BL 125158), and it was developed under a contract with the U.S. Centers for Disease Control and Prevention (CDC).Approved by the U.S. FDA on May 2, 2007, ACAM2000 Smallpox Vaccine is derived from plaque purification cloning from Dryvax®, calf lymph vaccine, and grown in African Green Monkey kidney (Vero) cells and tested to be free of adventitious agents. ACAM2000 replaced Dryvax for smallpox vaccinations in February 2008. The U.S. Department of Health and Human Services awarded a contract to Emergent in September 2019 valued at approximately $2 billion over ten years for the continued supply of ACAM2000® into the U.S. Strategic National Stockpile.ACAM2000 and JYNNEOS (Imvamune or Imvanex) are the two current U.S. FDA licensed vaccines to prevent smallpox, and JYNNEOS is explicitly licensed to prevent monkeypox. Gaithersburg, Maryland-based Emergent BioSolutions (NYSE: EBS) is a global life sciences company whose mission is to protect and enhance life. Emergent BioSolutions acquired ACAM2000 from Sanofi Pasteur for about $125 million cash in 2017-ACAM2000 is indicated for active immunization against smallpox disease for persons at high risk for smallpox infection. Smallpox vaccines are no longer routine, although some soldiers and laboratory workers still are inoculated. The U.S. FDA published Questions about Smallpox and ACAM2000. Please read this Medication Guide before you receive vaccination with ACAM2000. This Guide does not take the place of talking to your healthcare provider about ACAM2000 and the smallpox disease.ACAM2000, developed by Acambis, is a second-generation lyophilized preparation of purified virus (grown in Vero cell line) in HEPES (hydroxyethyl piperazine ethanesulfonic acid)-buffered saline, pH 7.4, containing 1% to 4% human serum albumin USP, 5% mannitol, and trace amounts of antibiotics (100 U/mL polymyxin B and 100 µg/mL neomycin) (John Becher, RPh, CDC, personal communication, 2006). It must be reconstituted before use by the addition of a diluent.ACAM2000 is administered as a single dose by the percutaneous route using the multiple punctures technique. The risk of side effects in household contacts is the same as those for the vaccine recipient. Therefore, the vaccination.

Monkeypox outbreaks in Canada and worldwide signal shift in behaviour of virus-Canada's 'entire population is susceptible,' says top official-Adam Miller · CBC News · Posted: May 21, 2022 4:00 AM ET |

Health officials are investigating about two dozen suspected cases of monkeypox across Canada, looking into possible chains of transmission for the virus. Despite a global outbreak, doctors say most infections don’t appear to result in severe cases.This is an excerpt from Second Opinion, CBC Health's weekly health and medical science newsletter. If you haven't subscribed yet, you can do that by clicking here.As the world races to understand more about rapidly emerging monkeypox outbreaks, the speed in which cases are being discovered  signals a major shift in the behaviour of the virus and its ability to spread from person to person unnoticed.Five cases of monkeypox have been confirmed in Quebec and Canada's chief public health officer said Friday provinces are continuing to investigate "a couple dozen" possible cases throughout Canada — with more likely to be confirmed in the days and weeks ahead.The World Health Organization (WHO) said Friday there are currently about 80 confirmed cases worldwide, with another 50 pending investigation and more likely to be reported as global surveillance expands.West and Central Africa typically see thousands of endemic cases reported annually, but monkeypox cases outside of Africa are rare and largely tied to travel. What sets this global outbreak apart is the rise in cases with no known travel origin. "The global spread is concerning. That's not something that we are particularly used to with monkeypox," said Jason Kindrachuk, University of Manitoba assistant professor of viral pathogenesis and Canada Research Chair of emerging viruses who has researched monkeypox."What we're seeing right now is unprecedented. We have multiple geographic locations across the globe that are reporting cases … What is the epidemiological link between these cases and is there anything that is related back to changes within the virus?" There are two main strains or "clades" of monkeypox: the Congo strain — which is more severe, with up to 10 per cent mortality — and the West African strain, which has a fatality rate of about one per cent.Transmission can result from close contact with respiratory secretions or the skin lesions of an infected person or from recently contaminated objects. Symptoms can include fever, intense headache, swelling of the lymph nodes, back pain, muscle aches, a lack of energy, severe rashes and lesions.The current strain circulating globally appears to be the West African, but genomic sequencing is currently ongoing in Canada and around the world to determine whether it has any distinct genetic mutations. "There's always that question of, have things changed?" said Kindrachuk. "What you're going to hear certainly over the next few weeks is a lot of information coming forth from people that have been looking specifically at samples from these patients and determining whether or not anything is different — so far, we haven't seen severe cases or fatal cases." William Hanage, an epidemiologist at the Harvard T.H. Chan School of Public Health and co-director of its Center for Communicable Disease Dynamics, says the strain looks closely related to what has circulated in West Africa in 2018, but more research is needed."It's certainly behaving differently in the sense that it's much more widespread. Because up until very recently, there had been a handful of countries outside Africa to which it had been introduced," he told CBC News. "There's obviously something different going on here. Now, what's making that difference is currently unknown." Hanage said the current strain of monkeypox circulating in at least 11 countries, including Canada, appears to be more transmissible, with a reproductive number likely above one, given that the global outbreak is continuing to grow in unknown size.But cases may also have been quietly spreading under the surface for months.A negative stain electron micrograph shows a mulberry-type monkeypox virus particle. The speed in which monkeypox cases are being discovered worldwide signals a major shift in the behaviour of the virus and its ability to spread from person to person unnoticed. (CDC)-"As soon as places started looking for it, they found it, which suggests not that it's spreading very fast but that it's been there for some time in relatively large numbers," he said. "Once you start targeting your testing at those distinctive lesions, you start to find it."The genome sequence from one of the first monkeypox cases identified in Portugal was uploaded Friday after the sample was received on May 4, but Hanage said it's "very reasonable" to suspect the outbreak "considerably predates" that case. "We don't know the true number of cases, but I think that it's important to bear in mind that this could have been transmitting for months and not have been noticed," he said. "Human behaviour has also flitted back and forth between some fairly extreme states the last few years, and now we are in a position where this virus is likely finding it more easy to transmit." -'How is it being transmitted?' Canada's Chief Public Health Officer Dr. Theresa Tam said Friday that genomic sequencing is currently being done at the National Microbiology Lab in Winnipeg to confirm any more cases in the days and weeks ahead. "We don't really know the extent to which the spread has occurred in Canada. That's under active investigation," she said during a news conference Friday. "So far we do know that not many of these individuals are connected to travel to Africa where the disease is usually seen. So this is unusual … to see this many cases reported in different countries outside of Africa." Tam said at the beginning of any outbreak, experts need to "cast a net wide" to try to understand the transmission routes of the virus, adding much remains unknown about this "unusual situation.""There's probably been some hidden chains of transmission that could have occurred for quite a number of weeks, given the global situation that we're seeing right now," she said."Most people haven't travelled, so how is it being transmitted?"Hanage says the most important factor in determining if an outbreak like this is controllable, is whether symptoms occur before or after a person becomes infectious."If a person is infectious before they develop symptoms, it's very hard to control," he said, "with poxviruses, classically, that is not the case. So a person develops the rash and it is at that point that they become infectious.""At the moment, we don't know that that's the case with this. But we have every reason to suspect that it would be but we still need to have it confirmed."Change in spread between humans-Another unusual characteristic of the monkeypox cases currently spreading around the world is the absence of transmission directly from animals to humans. "There's been very little evidence of human-to-human transmission, certainly outside Africa, until now," Hanage said. "It looks very much as if this is a lineage which has evolved the ability for human-to-human transmission. How? I don't know. Where? I have no idea."Hanage says another concern is patients who unknowingly develop mild symptoms but could still be infectious and may not realize they are at risk to others.Angela Rasmussen, a virologist and researcher with the University of Saskatchewan's Vaccine and Infectious Disease Organization (VIDO), says monkeypox usually spreads through close contact and inhalation — although not as readily as viruses like SARS-CoV-2.But it can also spread by direct and indirect contact, she says. "That means that there are a lot of opportunities potentially to spread it within situations where people are in prolonged close contact."Experts urge people not to panic over a handful of suspected cases of monkeypox under investigation in Quebec. It comes as infections appear to be spreading in several countries through close contact with others.'Every reason to be concerned' about containment-Rasmussen says there are numerous ways monkeypox outbreaks can be contained through classic epidemiological measures such as contact tracing, isolating people who were infected and quarantining those who may have been exposed. Failing that, "we do have a vaccine," she said. "We also have drugs that could be deployed that would certainly help in containment." Deputy Chief Public Health Officer Dr. Howard Njoo said Friday that, since Canada stopped smallpox vaccination campaigns in the early 1970s, those under 50 would not have any protection while older Canadians' immunity has likely waned."Generally, the entire population is susceptible," to monkeypox, Njoo said during a news conference. British health authorities took a bold step this week and moved to offer smallpox vaccines, which are somewhat effective against monkeypox, to some health-care workers and contacts who may have been exposed — using a so-called ring vaccination strategy. "There's every reason to be concerned about the capacity for containment, not least because of the fact that the weight of the containment is going to depend upon vaccines and very efficient use of them," said Hanage. "And the larger the problem becomes, the worse the position that we're starting from. So I think it's quite unlikely to be easily containable, but I wouldn't say that it is not necessarily containable. It's roll-up-your-sleeves and go-to-work time." Canada has been tight-lipped on its stockpile of smallpox vaccines, despite purchasing more than $30 million US worth of it last year that is expected to be delivered in 2023. Ottawa said Friday it was "exploring" ring vaccination with the World Health Organization and U.K. health officials."One thing which is very different from COVID, is that we have a vaccine. We don't necessarily have as much of it as we would like, but we have a vaccine. We don't need to be terrified about that particular future," said Hanage."It doesn't mean we've got it where it needs to be, but it does mean that we're starting from a completely different place."While Hanage says we're at a much better position compared to the beginning of the COVID-19 pandemic, the emergence of global monkeypox outbreaks underscores the need to fund and stay on top of previous threats. "The research has been underfunded for ages. I don't think that public health authorities have been paying it very much mind," he said. "And this just goes to show that if you turn your back on a virus it can jump up and bite you on the ass."

Monkeypox is almost nothing like COVID. Here’s what to know, from two Philly scientists who’ve studied it.Monkeypox is not going to cause a global health crisis. But the recent outbreak in Europe has experts puzzled. by Tom Avril-Published May 19, 2022

Among the many differences — fortunately, for a world weary of the pandemic — is that monkeypox is far less transmissible.So although a monkeypox case was identified Wednesday in Massachusetts, along with two in Canada and a handful earlier this month in Europe, infectious-disease experts say it won’t mean another global health crisis.Yet monkeypox is a serious disease, well worth monitoring so it can be contained with the standard tools of public health. Chief among them, in this case, are vaccines (yes, there already is one) and isolating infected people.Monkeypox is not new. Several thousand cases are reported each year, almost entirely in Africa, though some of the newly reported cases in Europe have no known link to Africa.Alas, social media already is rife with monkeypox misinformation, perhaps unsurprisingly for a disease with a name that sounds like something out of a bad disaster movie.To cut through the clutter, we spoke to Brian DeHaven, an associate professor of biology at La Salle University, and Stuart Isaacs, under whom DeHaven did a Ph.D. on pox viruses at the University of Pennsylvania’s Perelman School of Medicine.What causes monkeypox? Like COVID, monkeypox is caused by a virus. But the two microbes are not remotely related.Coronaviruses contain single strands of genetic material called RNA. The monkeypox virus carries its genetic code in DNA, which is double-stranded.The monkeypox virus is much larger than the one that causes COVID, and it produces proteins that disrupt the defenses in the human immune system.“They look kind of like bricks,” DeHaven said. “They are not subtle.”How does monkeypox spread? Monkeypox is so named because it was discovered in colonies of monkeys used for research in 1958.But it is unlikely that monkeys were the original source, said Isaacs, a virologist and associate professor at Penn. The virus also is carried by rodents.People can spread it to one another through contact with bodily fluids, lesions on the skin, or mucosal surfaces such as in the mouth or throat, the World Health Organization says. In the United Kingdom, health authorities say cases have predominantly occurred in men who have sex with men.Sex is not generally considered to be a route of transmission but is theoretically possible, Isaacs said.The monkeypox virus also can be spread by coughing, but generally through large droplets that fall to the ground within a few feet — not the lighter “aerosol” particles that remain aloft for minutes.As a result, it spreads much less readily between people than COVID. Each person with COVID tends to pass it on to multiple people, on average (provided they have no immunity), but some people with monkeypox do not pass it on to anyone, DeHaven said.“You get these flareups,” he said, “but then it burns out.”Still, said Isaacs, the disease may now be spreading more easily in Europe, and it is not clear why.“There seems to be some more human-to-human transmission than we might expect,” he said.What are the symptoms of monkeypox? Typically, monkeypox starts with flulike symptoms such as fever, intense headache, and swelling of the lymph nodes.After one to three days, a rash develops on the face and body, first appearing as flat lesions, progressing to pustules filled with yellowish fluid.Symptoms can last two to four weeks. Monkeypox can be deadly, but the death rate varies widely from strain to strain, from near zero to as high as 11%, according to the WHO.Is there a monkeypox vaccine? Yes. It’s the same as the one used to inoculate people against smallpox. It works because the two viruses are closely related, DeHaven said.Roughly speaking, the two viruses are about as similar to each other as two strains of the coronavirus that causes COVID.The smallpox vaccine was routinely administered in the United States until 1972, when that disease was eradicated in this country. As a result, most people under age 50 have no immunity to monkeypox or smallpox.But unlike with the vaccines for COVID, the smallpox vaccine is effective even after the start of an infection, if given promptly.Because human-to-human spread is limited, it is unlikely that public health officials would recommend widespread vaccination, Isaacs said. A more likely approach is “ring” vaccination — vaccinating the ring of close contacts around anyone who is infected.That’s why the CDC urges people with possible symptoms to contact their doctors.“People who may have symptoms of monkeypox, particularly men who report sex with other men, and those who have close contact with them, should be aware of any unusual rashes or lesions and contact their health-care provider for a risk assessment,” the agency says.Jimmy Whitworth, a professor of international public health at the London School of Hygiene and Tropical Medicine, told Reuters that while the recent outbreaks in Europe are “highly unusual,” there is no need for panic.“This isn’t going to cause a nationwide epidemic like COVID did, but it’s a serious outbreak of a serious disease – and we should take it seriously,” he said.How is chickenpox related to monkeypox?DistantlyLike monkeypox, the virus that causes chickenpox contains double-stranded DNA.But they’re on a different branch of the virus family tree. Despite the name, chickenpox is not a pox virus, but a herpes virus.In addition to monkeypox, the true pox viruses include smallpox and cowpox. Published May 19, 2022.

Monkeypox-Information for healthcare providers about monkeypox.Last updated: May 19, 2022 Monkeypox is a viral infection, caused by a virus of the Orthopoxvirus genus related to smallpox. Monkeypox is mostly present in Central and West African countries, but can be imported through travel. Clinical presentation resembles smallpox but is less severe. Since May 2022, United Kingdom, USA and European countries have seen rising cases of monkeypox. Although at least one UK case was related with travel to an African country, many cases didn’t report travel. Among these cases, a high proportion occurred in gay, bisexual and men who have sex with men. Monkeypox is not sexually transmitted but can be transmitted through direct contact. In Canada, some people are under investigation for exposure to monkeypox or who may have symptoms and signs of monkeypox. In BC, public health will follow up with individuals who may have been exposed to monkeypox.-Clinical presentation.Incubation: 5 to 21 days, usually 7 to 14 days.-Monkeypox infection has two clinical phases:A prodromal illness that lasts between 1 to 5 days followed by fever, intense headache, lymphadenophathy, back pain, myalgia, fatigue.A skin rash that begins 1-5 days after fever: rash evolves from maculopapular to vesicular lesions, pustules until crusting that scales off. Affected regions are: face (95 %), palms of soles and feet (75 %), oral mucous membranes (70 %), genitalia (30%), conjunctivae (20%) and cornea. Rash often begin on the face or genital area and spreads to other parts of the body. Number of lesions can vary from a few to thousands.Symptoms last 2 to 4 weeks.Children are at higher risk of severe disease. Potential complications include secondary infections, pneumonia, sepsis, encephalitis, keratitis with vision loss.Mortality differs according to the viral strain. Cases in UK were from the West African clade, which has a mortality of approximately 1%. Transmission-Period of communicability:  during the symptomatic period, including the prodrome. Lesions are considered infectious until the scabs fall off and new skin can be seen.

Global leaders unite in urgent call for international pandemic treaty-30 March 2021 News release-Geneva, Switzerland

25 heads of government and international agencies come together in extraordinary joint call- New treaty would signal high-level political action needed to protect the world from future health crisesThe international community should work together “towards a new international treaty for pandemic preparedness and response” to build a more robust global health architecture that will protect future generations, world leaders said in a commentary published today in several newspapers around the world.“There will be other pandemics and other major health emergencies. No single government or multilateral agency can address this threat alone,” the leaders say in their article. “The question is not if, but when. Together, we must be better prepared to predict, prevent, detect, assess and effectively respond to pandemics in a highly coordinated fashion. The COVID-19 pandemic has been a stark and painful reminder that nobody is safe until everyone is safe.”The main goal of a new international treaty for pandemic preparedness and response would be to foster a comprehensive, multi-sectoral approach to strengthen national, regional and global capacities and resilience to future pandemics. This is an opportunity for the world to come together as a global community for peaceful cooperation that extends beyond this crisis.According to the article, the treaty “would be rooted in the constitution of the World Health Organization, drawing in other relevant organizations key to this endeavour, in support of the principle of health for all. Existing global health instruments, especially the International Health Regulations, would underpin such a treaty, ensuring a firm and tested foundation on which we can build and improve.”The commentary has been signed by J. V. Bainimarama, Prime Minister of Fiji; Prayut Chan-o-cha, Prime Minister of Thailand; António Luís Santos da Costa, Prime Minister of Portugal; Mario Draghi, Prime Minister of Italy; Klaus  Iohannis, President of Romania; Boris Johnson, Prime Minister of the United Kingdom; Paul Kagame, President of Rwanda; Uhuru Kenyatta, President of Kenya; Emmanuel Macron, President of France; Angela Merkel, Chancellor of Germany; Charles Michel, President of the European Council; Kyriakos Mitsotakis, Prime Minister of Greece; Moon Jae-in, President of the Republic of Korea; Sebastián Piñera, President of Chile; Andrej Plenković, Prime Minister of Croatia; Carlos Alvarado Quesada, President of Costa Rica; Edi Rama, Prime Minister of Albania; Cyril Ramaphosa, President of South Africa; Keith Rowley, Prime Minister of Trinidad and Tobago; Mark Rutte, Prime Minister of the Netherlands; Kais Saied, President of Tunisia; Macky Sall, President of Senegal; Pedro Sánchez, Prime Minister of Spain; Erna Solberg, Prime Miniser of Norway; Aleksandar Vučić, President of Serbia; Joko Widodo, President of Indonesia; Volodymyr Zelensky, President of Ukraine Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization.

HERE ALREADY IS THE LIBERAL FAKE NEWS TRYING TO SAY THIS WORLD GOVERNMENT TREATY IS NOT CONTROLLED BY THE WHO. TRYING TO SAY ITS A CONSPIRACY THEORY.

No, ‘pandemic treaty’ would not give WHO control over governments during a global health crisis-Proposed amendments to international health regulations covered by the World Health Organization does not grant the WHO any new powers over countries.Author: Kelly Jones, Brandon Lewis-Updated: 1:02 PM PDT May 20, 2022

On May 22, the World Health Assembly will take place in Geneva, where World Health Organization member states will meet to discuss current and future priorities for public health issues of global importance. On the agenda is a U.S.-proposed change to international health rules. These rules set the standards for all countries to have the ability to detect, assess, report and respond to public health events.The proposed amendments outline new ideas to better respond to a pandemic. Across social media, users are referring to the amendments as the “pandemic treaty” and say it would grant the WHO “complete health sovereignty,” and unlimited authority over governments in a global health crisis. If the WHO pandemic treaty is signed, your vote will never ever count again. #StopTheTreaty — Southeerner (@whatgives1313) May 17, 2022-On a podcast hosted by Steve Bannon, former Minnesota Representative Michele Bachmann also claimed the amendments could give the WHO sovereignty over the United States.Several VERIFY viewers asked us to look into what powers the WHO would have should the amendments pass.THE QUESTION-Would the “pandemic treaty” provide the WHO control over governments during a global health crisis? (YES) (NO BY THE LIBERAL FAKE PROPAGANDA LIBERAL NEWS MEDIA)

Sophie Grégoire Trudeau among 26 more Canadians banned from travel to Russia-Chrystia Freeland's husband, defence contractors also on expanded sanctions list-Thomson Reuters · Posted: May 21, 2022 11:16 AM ET

Prime Minister Justin Trudeau and Sophie Grégoire Trudeau arrive for the cabinet swearing-in ceremony at Rideau Hall in Ottawa on Oct. 26, 2021. On Saturday, Grégoire Trudeau was added to a list of Canadians banned from entering Russia. (Adrian Wyld/The Canadian Press)-Russia said on Saturday it had added 26 new names to a list of Canadians it has barred from travelling to the country, including defence chiefs, defence industry executives and Sophie Grégoire Trudeau, the wife of Prime Minister Justin Trudeau.In response to economic sanctions, Russia has already banned Trudeau, Finance Minister Chrystia Freeland and hundreds of other Canadians from entering the country.The new Canadian list was published four days after Canada introduced a bill that will ban Russian President Vladimir Putin and about 1,000 members of his government and military from travelling there.The list also includes Lt.-Gen. Jocelyn Paul, Maj.-Gen. Eric Kenny and Rear Admiral Angus Topshee, who were named last month as the new heads of the Canadian army, air force and navy, respectively, and executives of companies including Lockheed Martin Canada and Raytheon Canada.Russia also said it had so far banned 963 Americans from entering the country — including previously announced moves against President Joe Biden and other top officials — and would continue to retaliate against what it called hostile U.S. actions.The largely symbolic travel bans form part of a downward spiral in Russia's relations with the West since its Feb. 24 invasion of Ukraine, which prompted Washington and its allies to impose drastic sanctions on Moscow and step up arms supplies to Ukraine.Publishing the full list of banned Americans for the first time, the Russian government said: "We emphasize that the hostile actions taken by Washington, which boomerang against the United States itself, will continue to receive a proper rebuff."It said Russian counter-sanctions were a necessary response aimed at "forcing the ruling American regime, which is trying to impose a neo-colonial 'rules-based world order' on the rest of the world, to change its behaviour, recognizing new geopolitical realities."Previously announced names on the huge list included Secretary of State Antony Blinken, Defence Secretary Lloyd Austin and CIA chief William Burns.